Analyst firms · Wolfe Research · VERA
Wolfe Research VERA price target and rating history
Vera Therapeutics Inc. (VERA) · Health Care
Wolfe Research rates Vera Therapeutics Inc. (VERA) Outperform with a $88 price target, as of its latest action on Mar 11, 2026. It has published 3 rating actions on VERA since February 2025, including 1 upgrade and 1 downgrade.
- Current rating
- Outperform
- Price target
- $88
- Median target, all firms
- Too few
- Actions on VERA
- 3
Wolfe Research price target on VERA
Every Wolfe Research rating on VERA
- Mar 11, 2026
- Aug 4, 2025
- Feb 4, 2025
How other firms rate VERA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Leerink Partners | Market Perform | $34 | Oct 12, 2026 |
| Wolfe Research | Outperform | $88 | Mar 11, 2026 |
Questions about Wolfe Research and VERA
- What is Wolfe Research's price target for VERA?
- Wolfe Research's latest stated price target for Vera Therapeutics Inc. (VERA) is $88, from its action on Mar 11, 2026.
- What is Wolfe Research's rating on VERA?
- Wolfe Research rates VERA Outperform, a bullish rating, as of Mar 11, 2026.
- When did Wolfe Research last change its view on VERA?
- On Mar 11, 2026, Wolfe Research upgrades to Outperform from Peer Perform, price target $88.
All Wolfe Research ratingsVERA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.